BridgeBio Pharma, Inc. SEC filings BBIO

BridgeBio Pharma, Inc. has 833 filings in SEC EDGAR's recent list, going back to Jun 19, 2018. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

BridgeBio Pharma, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Nov 3, 2026 Oct 30, 2026
SCHEDULE 13G Ownership over 5% (passive) Oct 27, 2026 —
4 Insider transaction Sep 21, 2026 Sep 17, 2026
4 Insider transaction Aug 20, 2026 Aug 18, 2026
144 Notice of proposed sale Aug 19, 2026 —
4 Insider transaction Aug 18, 2026 Aug 16, 2026
4 Insider transaction Aug 18, 2026 Aug 16, 2026
4 Insider transaction Aug 18, 2026 Aug 16, 2026
144 Notice of proposed sale Aug 18, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 17, 2026 —
144 Notice of proposed sale Aug 17, 2026 —
4 Insider transaction Aug 3, 2026 Jul 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 3, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 27, 2026 —
4 Insider transaction Jul 13, 2026 Jul 9, 2026
4 Insider transaction Jul 13, 2026 Jul 9, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 10, 2026 —
144 Notice of proposed sale Jul 9, 2026 —
144 Notice of proposed sale Jul 9, 2026 —
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
144 Notice of proposed sale Jun 24, 2026 —
144 Notice of proposed sale Jun 24, 2026 —
4 Insider transaction Jun 23, 2026 Jun 20, 2026
144 Notice of proposed sale Jun 23, 2026 —
144 Notice of proposed sale Jun 23, 2026 —
144 Notice of proposed sale Jun 22, 2026 —
4 Insider transaction Jun 17, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 15, 2026 —
4 Insider transaction Jun 8, 2026 Jun 4, 2026
SCHEDULE 13G Ownership over 5% (passive) May 29, 2026 —
4 Insider transaction May 26, 2026 May 21, 2026
144 Notice of proposed sale May 21, 2026 —
4 Insider transaction May 19, 2026 May 16, 2026
4 Insider transaction May 19, 2026 May 16, 2026
4 Insider transaction May 19, 2026 May 16, 2026
4 Insider transaction May 19, 2026 May 15, 2026
144 Notice of proposed sale May 18, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
4 Insider transaction May 11, 2026 May 7, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 16, 2026 —
4 Insider transaction Apr 13, 2026 Apr 9, 2026
144 Notice of proposed sale Apr 9, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 2, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 20, 2026 Mar 18, 2026
4 Insider transaction Mar 20, 2026 Mar 18, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 16, 2026 Mar 12, 2026
144 Notice of proposed sale Mar 13, 2026 —
4 Insider transaction Mar 12, 2026 Mar 10, 2026
144 Notice of proposed sale Mar 10, 2026 —
4 Insider transaction Mar 6, 2026 Mar 4, 2026
144 Notice of proposed sale Mar 4, 2026 —
4 Insider transaction Mar 3, 2026 Feb 27, 2026
144 Notice of proposed sale Feb 27, 2026 —
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 23, 2026 Feb 19, 2026
144 Notice of proposed sale Feb 19, 2026 —
4 Insider transaction Feb 18, 2026 Feb 16, 2026
4 Insider transaction Feb 18, 2026 Feb 16, 2026
4 Insider transaction Feb 18, 2026 Feb 16, 2026
4 Insider transaction Feb 18, 2026 Feb 17, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 17, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Feb 12, 2026 Feb 10, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
144 Notice of proposed sale Jan 8, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
4 Insider transaction Dec 16, 2025 Dec 12, 2025
4 Insider transaction Dec 16, 2025 Dec 12, 2025
4 Insider transaction Dec 16, 2025 Dec 12, 2025
144 Notice of proposed sale Dec 15, 2025 —
4 Insider transaction Dec 10, 2025 Dec 8, 2025
4 Insider transaction Dec 8, 2025 Dec 4, 2025
4 Insider transaction Nov 24, 2025 Nov 20, 2025
144 Notice of proposed sale Nov 20, 2025 —
4 Insider transaction Nov 19, 2025 Nov 17, 2025
4 Insider transaction Nov 19, 2025 Nov 17, 2025
4 Insider transaction Nov 18, 2025 Nov 16, 2025
4 Insider transaction Nov 18, 2025 Nov 16, 2025
4 Insider transaction Nov 18, 2025 Nov 16, 2025
144 Notice of proposed sale Nov 18, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Nov 14, 2025 —
4 Insider transaction Nov 14, 2025 Nov 12, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
144 Notice of proposed sale Nov 12, 2025 —
4 Insider transaction Nov 10, 2025 Nov 6, 2025
4 Insider transaction Nov 7, 2025 Nov 6, 2025
144 Notice of proposed sale Nov 6, 2025 —
4 Insider transaction Oct 31, 2025 Oct 29, 2025
144 Notice of proposed sale Oct 29, 2025 —
4 Insider transaction Oct 29, 2025 Oct 27, 2025
144 Notice of proposed sale Oct 27, 2025 —
4 Insider transaction Oct 16, 2025 Oct 10, 2025
4 Insider transaction Oct 10, 2025 Oct 8, 2025
144 Notice of proposed sale Oct 8, 2025 —
144 Notice of proposed sale Oct 8, 2025 —
4 Insider transaction Sep 8, 2025 Sep 5, 2025
4 Insider transaction Sep 8, 2025 Sep 4, 2025
144 Notice of proposed sale Sep 5, 2025 —
4 Insider transaction Aug 22, 2025 Aug 21, 2025
4 Insider transaction Aug 22, 2025 Aug 20, 2025
144 Notice of proposed sale Aug 21, 2025 —
144 Notice of proposed sale Aug 20, 2025 —
4 Insider transaction Aug 19, 2025 Aug 16, 2025
4 Insider transaction Aug 19, 2025 Aug 16, 2025
4 Insider transaction Aug 19, 2025 Aug 16, 2025
3 Initial insider ownership Aug 18, 2025 Aug 11, 2025
144 Notice of proposed sale Aug 18, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 14, 2025 —
4 Insider transaction Aug 12, 2025 Aug 8, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
4 Insider transaction Aug 11, 2025 Aug 7, 2025
144 Notice of proposed sale Aug 11, 2025 —
144 Notice of proposed sale Aug 8, 2025 —
4 Insider transaction Aug 7, 2025 Aug 5, 2025
144 Notice of proposed sale Aug 5, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2025 —
4 Insider transaction Jul 3, 2025 Jul 1, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 1, 2025 —
4 Insider transaction Jul 1, 2025 Jun 27, 2025
144 Notice of proposed sale Jul 1, 2025 —
144 Notice of proposed sale Jul 1, 2025 —
4 Insider transaction Jun 30, 2025 Jun 27, 2025
4 Insider transaction Jun 30, 2025 Jun 26, 2025
4/A Filing Jun 30, 2025 Dec 29, 2021
4/A Filing Jun 30, 2025 Dec 28, 2021
4 Insider transaction Jun 26, 2025 Jun 24, 2025
144 Notice of proposed sale Jun 26, 2025 —
144 Notice of proposed sale Jun 26, 2025 —
144 Notice of proposed sale Jun 26, 2025 —
144 Notice of proposed sale Jun 26, 2025 —
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
144 Notice of proposed sale Jun 24, 2025 —
4 Insider transaction Jun 11, 2025 Jun 10, 2025
144 Notice of proposed sale Jun 10, 2025 —
4 Insider transaction May 20, 2025 May 16, 2025
4 Insider transaction May 20, 2025 May 16, 2025
4 Insider transaction May 20, 2025 May 16, 2025
144 Notice of proposed sale May 19, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) May 14, 2025 —
4 Insider transaction May 14, 2025 May 12, 2025
144 Notice of proposed sale May 12, 2025 —
4 Insider transaction May 9, 2025 May 7, 2025
4 Insider transaction May 6, 2025 May 2, 2025
4 Insider transaction May 6, 2025 May 2, 2025
144 Notice of proposed sale May 2, 2025 —
4 Insider transaction Apr 24, 2025 Apr 22, 2025
4 Insider transaction Apr 16, 2025 Apr 14, 2025
144 Notice of proposed sale Apr 14, 2025 —
4 Insider transaction Apr 3, 2025 Apr 1, 2025
144 Notice of proposed sale Apr 2, 2025 —
4 Insider transaction Mar 27, 2025 Mar 25, 2025
4 Insider transaction Mar 21, 2025 Mar 19, 2025
4 Insider transaction Mar 21, 2025 Mar 19, 2025
4 Insider transaction Mar 21, 2025 Mar 19, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 12, 2025 —
4 Insider transaction Mar 10, 2025 Mar 6, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 7, 2025 —
4 Insider transaction Mar 7, 2025 Mar 5, 2025
144 Notice of proposed sale Mar 6, 2025 —
144 Notice of proposed sale Mar 5, 2025 —
3 Initial insider ownership Feb 27, 2025 Feb 19, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
144 Notice of proposed sale Feb 25, 2025 —
144 Notice of proposed sale Feb 25, 2025 —
4 Insider transaction Feb 19, 2025 Feb 16, 2025
4 Insider transaction Feb 19, 2025 Feb 16, 2025
4 Insider transaction Feb 19, 2025 Feb 16, 2025
144 Notice of proposed sale Feb 19, 2025 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BBIO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Palo Alto, CA
SEC filer status
Large accelerated filer
SEC CIK
1743881
Former names
BridgeBio Pharma LLC (until May 16, 2019)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.